IMPACT, the UK’s first ever clinical trials partnership dedicated to improving the outcomes for blood cancer and stem cell transplant patients, has appointed Professor Ronjon Chakraverty as Medical Director. Ronjon Chakraverty is currently Professor of Haematology at the University of Oxford. He previously led the merger of the Royal Free and University College London Hospital Haematology […]
Read More… from IMPACT appoints Professor Ronjon Chakraverty as Medical Director
